
- Price
- $93.06
- Day
- -1.30%
- Mkt Cap
- $11.25B
- 52W Range
- $84.70 – $128.90
- Volume
- 2.20M
- Beta
- 0.54

Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.

CLX is using cost savings, ERP optimization and pricing to cushion inflation, but the FY27 gross margin is still projected at 42%.
Read full article
Clorox (CLX) reported earnings 30 days ago. What's next for the stock?
Read full article
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Clorox (CLX). But which of these two stocks offers value investors a better bang for their buck right now?
Read full article
Canada Pension Plan Investment Board purchased a new position in shares of The Clorox Company (NYSE: CLX) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 32,488 shares of the company's stock, valued at approximately $3,101,000. Other large investors also
Read full article
Buy these undervalued dividend stocks that have healthy yields to generate dependable income.
Read full article
Barrow Hanley Mewhinney and Strauss LLC bought a new position in shares of The Clorox Company (NYSE: CLX) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 106,377 shares of the company's stock, valued at approximately $10,153,000.
Read full article
Bank of New York Mellon Corp acquired a new position in shares of The Clorox Company (NYSE: CLX) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,290,384 shares of the company's stock, valued at approximately $123,154,000. Bank of New
Read full article
Clorox (CLX +0.45%) could be an interesting stock to consider for dividend investors.
Read full article
BlackRock Inc. purchased a new stake in The Clorox Company (NYSE: CLX) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 10,044,423 shares of the company's stock, valued at approximately $958,640,000. BlackRock Inc. owned 8.31% of Clorox as of its most
Read full article
I reiterate a Hold rating on The Clorox Company, as the current valuation requires unsustainably high free cash flow growth. Recent positives include the GOJO acquisition and ERP rollout, but organic revenue growth remains limited after adjusting for these factors. CLX's balance sheet is heavily leveraged post-acquisition, constraining reinvestment and raising dividend sustainability concerns.
Read full article
CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.
Read full article
CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.
Read full article